Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen
| Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen |
| Autore | Peace Karl E. <1941, > |
| Pubbl/distr/stampa | Boca Raton : , : Chapman and Hall/CRC Press, , 2011 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina | 615.5072/4 |
| Altri autori (Persone) | ChenDing-Geng |
| Collana | Chapman & Hall/CRC biostatistics series |
| Soggetto topico |
Clinical trials
Drugs - Testing |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-429-14207-2
1-58488-918-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Contents; Preface; Chapter 1: Overview of Clinical Trial Methodology; Chapter 2: Overview of the Drug Development Processand Regulation of Clinical Trials; Chapter 3: Ethical Considerations in the Designand Conduct of Clinical Trials; Chapter 4: Sample Size Considerations in ClinicalTrials Pre-Market Approval; Chapter 5: Sequential, Group Sequential, StochasticCurtailment, and Adaptive DesignProcedures in Clinical Trials; Chapter 6: Biostatistical Aspects of the Protocol; Chapter 7: The Statistical Analysis Plan; Chapter 8: Pooling of Data from Multicenter Clinical Trials
Chapter 9: Validity of Statistical InferenceChapter 10: Bioequivalence Clinical Trials; Chapter 11: Dose and Frequency Determinationfrom Phase II Clinical Trials in StressTest-Induced Angina; Chapter 12: Confirmation of Clinically Optimal Dosingin the Treatment of Duodenal Ulcers:A Phase III Dose Comparison Trial; Chapter 13: Pivotal Proof-of-Efficacy Clinical Trialsin the Prevention of NANSAID-InducedGastric Ulceration; Chapter 14: Clinical Trials in the Treatmentof Alzheimer's Disease Based uponEnrichment Designs; Chapter 15: A Clinical Trial to Establish Reductionof CHD Risk Chapter 16: Pivotal Proof-of-Efficacy Clinical Trialsin the Treatment of Panic DisorderChapter 17: Combination Clinical Trials; Chapter 18: Monitoring Clinical Trials for Adverse Events; Index; Back cover |
| Record Nr. | UNINA-9910458853903321 |
Peace Karl E. <1941, >
|
||
| Boca Raton : , : Chapman and Hall/CRC Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen
| Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen |
| Autore | Peace Karl E. <1941, > |
| Pubbl/distr/stampa | Boca Raton : , : Chapman and Hall/CRC Press, , 2011 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina | 615.5072/4 |
| Altri autori (Persone) | ChenDing-Geng |
| Collana | Chapman & Hall/CRC biostatistics series |
| Soggetto topico |
Clinical trials
Drugs - Testing |
| ISBN |
0-429-14207-2
1-58488-918-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Contents; Preface; Chapter 1: Overview of Clinical Trial Methodology; Chapter 2: Overview of the Drug Development Processand Regulation of Clinical Trials; Chapter 3: Ethical Considerations in the Designand Conduct of Clinical Trials; Chapter 4: Sample Size Considerations in ClinicalTrials Pre-Market Approval; Chapter 5: Sequential, Group Sequential, StochasticCurtailment, and Adaptive DesignProcedures in Clinical Trials; Chapter 6: Biostatistical Aspects of the Protocol; Chapter 7: The Statistical Analysis Plan; Chapter 8: Pooling of Data from Multicenter Clinical Trials
Chapter 9: Validity of Statistical InferenceChapter 10: Bioequivalence Clinical Trials; Chapter 11: Dose and Frequency Determinationfrom Phase II Clinical Trials in StressTest-Induced Angina; Chapter 12: Confirmation of Clinically Optimal Dosingin the Treatment of Duodenal Ulcers:A Phase III Dose Comparison Trial; Chapter 13: Pivotal Proof-of-Efficacy Clinical Trialsin the Prevention of NANSAID-InducedGastric Ulceration; Chapter 14: Clinical Trials in the Treatmentof Alzheimer's Disease Based uponEnrichment Designs; Chapter 15: A Clinical Trial to Establish Reductionof CHD Risk Chapter 16: Pivotal Proof-of-Efficacy Clinical Trialsin the Treatment of Panic DisorderChapter 17: Combination Clinical Trials; Chapter 18: Monitoring Clinical Trials for Adverse Events; Index; Back cover |
| Record Nr. | UNINA-9910785026803321 |
|
Peace Karl E. <1941, >
|
||
| Boca Raton : , : Chapman and Hall/CRC Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen
| Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen |
| Autore | Peace Karl E. <1941, > |
| Pubbl/distr/stampa | Boca Raton : , : Chapman and Hall/CRC Press, , 2011 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina | 615.5072/4 |
| Altri autori (Persone) | ChenDing-Geng |
| Collana | Chapman & Hall/CRC biostatistics series |
| Soggetto topico |
Clinical trials
Drugs - Testing |
| ISBN |
0-429-14207-2
1-58488-918-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Contents; Preface; Chapter 1: Overview of Clinical Trial Methodology; Chapter 2: Overview of the Drug Development Processand Regulation of Clinical Trials; Chapter 3: Ethical Considerations in the Designand Conduct of Clinical Trials; Chapter 4: Sample Size Considerations in ClinicalTrials Pre-Market Approval; Chapter 5: Sequential, Group Sequential, StochasticCurtailment, and Adaptive DesignProcedures in Clinical Trials; Chapter 6: Biostatistical Aspects of the Protocol; Chapter 7: The Statistical Analysis Plan; Chapter 8: Pooling of Data from Multicenter Clinical Trials
Chapter 9: Validity of Statistical InferenceChapter 10: Bioequivalence Clinical Trials; Chapter 11: Dose and Frequency Determinationfrom Phase II Clinical Trials in StressTest-Induced Angina; Chapter 12: Confirmation of Clinically Optimal Dosingin the Treatment of Duodenal Ulcers:A Phase III Dose Comparison Trial; Chapter 13: Pivotal Proof-of-Efficacy Clinical Trialsin the Prevention of NANSAID-InducedGastric Ulceration; Chapter 14: Clinical Trials in the Treatmentof Alzheimer's Disease Based uponEnrichment Designs; Chapter 15: A Clinical Trial to Establish Reductionof CHD Risk Chapter 16: Pivotal Proof-of-Efficacy Clinical Trialsin the Treatment of Panic DisorderChapter 17: Combination Clinical Trials; Chapter 18: Monitoring Clinical Trials for Adverse Events; Index; Back cover |
| Record Nr. | UNINA-9910799965803321 |
|
Peace Karl E. <1941, >
|
||
| Boca Raton : , : Chapman and Hall/CRC Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen
| Clinical trial methodology / / Karl E. Peace, Ding-Geng (Din) Chen |
| Autore | Peace Karl E. <1941, > |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boca Raton : , : Chapman and Hall/CRC Press, , 2011 |
| Descrizione fisica | 1 online resource (422 p.) |
| Disciplina |
615.5072/4
615.50724 |
| Altri autori (Persone) | ChenDing-Geng |
| Collana | Chapman & Hall/CRC biostatistics series |
| Soggetto topico |
Clinical trials
Drugs - Testing |
| ISBN |
0-429-14207-2
1-58488-918-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Contents; Preface; Chapter 1: Overview of Clinical Trial Methodology; Chapter 2: Overview of the Drug Development Processand Regulation of Clinical Trials; Chapter 3: Ethical Considerations in the Designand Conduct of Clinical Trials; Chapter 4: Sample Size Considerations in ClinicalTrials Pre-Market Approval; Chapter 5: Sequential, Group Sequential, StochasticCurtailment, and Adaptive DesignProcedures in Clinical Trials; Chapter 6: Biostatistical Aspects of the Protocol; Chapter 7: The Statistical Analysis Plan; Chapter 8: Pooling of Data from Multicenter Clinical Trials
Chapter 9: Validity of Statistical InferenceChapter 10: Bioequivalence Clinical Trials; Chapter 11: Dose and Frequency Determinationfrom Phase II Clinical Trials in StressTest-Induced Angina; Chapter 12: Confirmation of Clinically Optimal Dosingin the Treatment of Duodenal Ulcers:A Phase III Dose Comparison Trial; Chapter 13: Pivotal Proof-of-Efficacy Clinical Trialsin the Prevention of NANSAID-InducedGastric Ulceration; Chapter 14: Clinical Trials in the Treatmentof Alzheimer's Disease Based uponEnrichment Designs; Chapter 15: A Clinical Trial to Establish Reductionof CHD Risk Chapter 16: Pivotal Proof-of-Efficacy Clinical Trialsin the Treatment of Panic DisorderChapter 17: Combination Clinical Trials; Chapter 18: Monitoring Clinical Trials for Adverse Events; Index; Back cover |
| Record Nr. | UNINA-9910817366103321 |
|
Peace Karl E. <1941, >
|
||
| Boca Raton : , : Chapman and Hall/CRC Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||